DEVELOPMENT OF AUTONOMOUSLY REPLICATING VIRAL RNA TO EXPRESS THE RECOMBINANT HUMAN GRANULOCYTE COLONY-STIMULATING FACTOR

Makhabbat Kaliyeva; Alexander Shustov

doi:10.12955/cbup.v3.629

Makhabbat Kaliyeva National Center for Biotechnology
Alexander Shustov National Center for Biotechnology

DOI: https://doi.org/10.12955/cbup.v3.629

Keywords: RNA virus, autonomously replicating RNA, replicon, Venezuelan equine, encephalomyelitis virus, granulocyte colony-stimulating factor, eukaryotic expression

Abstract

Recombinant human granulocyte colony-stimulating factor (G-CSF) produced in cultured mammalian cells undergoes proper posttranslational modifications and, thereby, possesses better pharmacological properties in comparison with the homologous protein expressed in bacteria. Biopharmaceuticals derived from cell culture tend to be expensive because of lower yields compared to bacterially expressed competitors and numerous issues with the scalability of production. Particular limitation of scalability pertains to delivery of expression vectors to the cell culture. Natural and efficient way to deliver foreign DNA or RNA to cell is a viral infection. We intended to develop the viral genome capable of G-CSF expression.

Objectives: To develop autonomously replicating viral RNA capable of heterologous expression of the G-CSF in cultured mammalian cells.

Methods: Genetic engineering, cell culture, and virology.

Results: Viable genome of the Venezuelan equine encephalomyelitis virus (VEE) was constructed. The G-CSF gene was synthesized de novo. Gene cassette GFP-2A-G-CSF was constructed for simultaneous expression of the fluorescent marker of viral replication (GFP) and the product of interest. Recombinant viral genome VEE/GFP-2A-G-CSF was assembled; its viability was confirmed upon transfection to the BHK-21 cells.

Conclusion: Genetic engineering of the cDNA copies of the genomes of RNA viruses provides excessive opportunities to develop mammalian expression systems. We achieved production of recombinant proteins in cultured mammalian cells transfected with the VEE viral RNA carrying the inserted genes of marker protein and G-CSF.

References

Ataergin, S., Arpaci, F., Turan, M., Solchaga, L., Cetin, T., Ozturk, M., Ozet, A., Komurcu, S., & Ozturk, B. (2008). Reduced dose of lenograstim is as efficacious as standard dose of filgrastim for peripheral blood stem cell mobilization and transplantation: a randomized study in patients undergoing autologous peripheral stem cell transplantation. American Journal of Hematology, 83(8), 644-648.

Bernal, J. A. (2013). RNA-based tools for nuclear reprogramming and lineage-conversion: towards clinical applications. Journal of Cardiovascular Translational Research, 6(6), 956-968.

Boubeva, R., Reichert, C., Handrick, R., Müller, C., Hannemann, J., & Borcharda, G. (2012). New expression method and characterization of recombinant human granulocyte colony-stimulating factor in a stable protein formulation. CHIMIA International Journal for Chemistry, 66(5), 281-285.

Davis, N. L., Powell, N., Greenwald, G. F., Willis, L. V., Johnson, B. J., Smith, J. F., &Johnston, R. E. (1991). Attenuating mutations in the E2 glycoprotein gene of Venezuelan equine encephalitis virus: construction of single and multiple mutants in a full-length cDNA clone. Virology, 183(1), 20-31.

Hahn, Y. S., Strauss, E. G., &Strauss, J. H. (1989). Mapping of RNA - temperature-sensitive mutants of Sindbis virus: assignment of complementation groups A, B, and G to nonstructural proteins. Journal of Virology, 63(7), 3142-3150.

Kuhn, R. J., Niesters, H. G., Hong, Z., &Strauss, J. H. (1991). Infectious RNA transcripts from Ross River virus cDNA clones and the construction and characterization of defined chimeras with Sindbis virus. Virology, 182(2), 430-441.

Li, M., Fan, H., Liu, J., Wang, M., Wang, L., &Wang, C. (2012). High pH solubilization and chromatography-based renaturation and purification of recombinant human granulocyte colony-stimulating factor from inclusion bodies. Applied Biochemistry and Biotechnology, 166(5), 1264-1274.

Liljestrom, P., & Garoff, H. (1991). A new generation of animal cell expression vectors based on the Semliki Forest virus replicon. Biotechnology (NY), 9(12), 1356-1361.

Liljestrom, P., Lusa, S., Huylebroeck, D., & Garoff, H. (1991). In vitro mutagenesis of a full-length cDNA clone of Semliki Forest virus: the small 6,000-molecular-weight membrane protein modulates virus release. Journal of Virology, 65(8), 4107-4113.

Núñez, E. G. F., Jorge, S. A. C., Astray, R. M., de Rezende, A. G., da Costa, B. L. V., Monteiro, D. C. V., Pereira, C. A., & Tonso, A. (2013). Semliki forest virus as a vector: pros and cons for its use in biopharmaceuticals production. Brazilian Archives of Biology and Technology, 56(5), 859-866.

Rice, C. M., Levis, R., Strauss, J. H., &Huang, H. V. (1987). Production of infectious RNA transcripts from Sindbis virus cDNA clones: mapping of lethal mutations, rescue of a temperature-sensitive marker, and in vitro mutagenesis to generate defined mutants. Journal of Virology,61(12), 3809-3819.

Triozzi, P. L., Achberger, S., Aldrich, W., Elson, P., Garcia, J., & Dreicer, R. (2012). Differential immunologic and microRNA effects of 2 dosing regimens of recombinant human granulocyte/macrophage colony-stimulating factor. Journal of Immunotherapy,35(7), 587-594.

Xiong, C., Levis, R., Shen, P., Schlesinger, S., Rice, C. M., &Huang, H. V. (1989). Sindbis virus: an efficient, broad host range vector for gene expression in animal cells. Science, 243(4895), 1188-1191.